CERo Therapeutics Holdings, Inc.
CERO
$0.04
$0.008.70%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 105.40K | 500.00K | -- | -- | -- |
| Gross Profit | -105.40K | -500.00K | -- | -- | -- |
| SG&A Expenses | 3.80M | 1.98M | 2.68M | 2.20M | 2.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.53M | 4.86M | 5.43M | 5.11M | 2.10M |
| Operating Income | -4.53M | -4.86M | -5.43M | -5.11M | -2.10M |
| Income Before Tax | -4.54M | -4.86M | -5.42M | -5.11M | 671.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.54M | -4.86M | -5.42M | -5.11M | 671.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.54M | -4.86M | -5.42M | -5.11M | 671.90K |
| EBIT | -4.53M | -4.86M | -5.43M | -5.11M | -2.10M |
| EBITDA | -4.46M | -4.79M | -5.36M | -5.03M | -2.00M |
| EPS Basic | -3.23 | -9.10 | -61.71 | -33.42 | -47.06 |
| Normalized Basic EPS | -0.19 | -2.40 | -6.94 | -19.55 | -22.76 |
| EPS Diluted | -3.23 | -9.10 | -61.71 | -33.42 | -47.06 |
| Normalized Diluted EPS | -0.19 | -2.40 | -6.94 | -19.55 | -22.76 |
| Average Basic Shares Outstanding | 14.98M | 1.26M | 488.10K | 3.60M | 57.10K |
| Average Diluted Shares Outstanding | 14.98M | 1.26M | 488.10K | 3.60M | 57.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |